These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23181284)
1. Identification of potential universal vaccine candidates against group A Streptococcus by using high throughput in silico and proteomics approach. Sharma A; Arya DK; Sagar V; Bergmann R; Chhatwal GS; Johri AK J Proteome Res; 2013 Jan; 12(1):336-46. PubMed ID: 23181284 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein. Bauer MJ; Georgousakis MM; Vu T; Henningham A; Hofmann A; Rettel M; Hafner LM; Sriprakash KS; McMillan DJ Vaccine; 2012 Mar; 30(12):2197-205. PubMed ID: 22265945 [TBL] [Abstract][Full Text] [Related]
3. Comparative in silico analysis of two vaccine candidates for group A streptococcus predicts that they both may have similar safety profiles. Shaila MS; Nayak R; Prakash SS; Georgousakis M; Brandt E; McMillan DJ; Batzloff MR; Pruksakorn S; Good MF; Sriprakash KS Vaccine; 2007 May; 25(18):3567-73. PubMed ID: 17293014 [TBL] [Abstract][Full Text] [Related]
4. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins. Lei B; Liu M; Chesney GL; Musser JM J Infect Dis; 2004 Jan; 189(1):79-89. PubMed ID: 14702157 [TBL] [Abstract][Full Text] [Related]
5. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS. Smeesters PR; Dramaix M; Van Melderen L Vaccine; 2010 Jan; 28(4):883-5. PubMed ID: 19963033 [No Abstract] [Full Text] [Related]
6. Identification and assessment of new vaccine candidates for group A streptococcal infections. McMillan DJ; Batzloff MR; Browning CL; Davies MR; Good MF; Sriprakash KS; Janulczyk R; Rasmussen M Vaccine; 2004 Jul; 22(21-22):2783-90. PubMed ID: 15246612 [TBL] [Abstract][Full Text] [Related]
8. Group a streptococcal vaccine candidates: potential for the development of a human vaccine. Henningham A; Gillen CM; Walker MJ Curr Top Microbiol Immunol; 2013; 368():207-42. PubMed ID: 23250780 [TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population. Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610 [TBL] [Abstract][Full Text] [Related]
10. Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development. Smeesters PR; Mardulyn P; Vergison A; Leplae R; Van Melderen L Vaccine; 2008 Oct; 26(46):5835-42. PubMed ID: 18789365 [TBL] [Abstract][Full Text] [Related]
11. Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci. Good MF; Pandey M; Batzloff MR; Tyrrell GJ Expert Rev Vaccines; 2015; 14(11):1459-70. PubMed ID: 26485214 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. McNeil SA; Halperin SA; Langley JM; Smith B; Warren A; Sharratt GP; Baxendale DM; Reddish MA; Hu MC; Stroop SD; Linden J; Fries LF; Vink PE; Dale JB Clin Infect Dis; 2005 Oct; 41(8):1114-22. PubMed ID: 16163629 [TBL] [Abstract][Full Text] [Related]
13. Group A streptococcal vaccines: facts versus fantasy. Steer AC; Batzloff MR; Mulholland K; Carapetis JR Curr Opin Infect Dis; 2009 Dec; 22(6):544-52. PubMed ID: 19797947 [TBL] [Abstract][Full Text] [Related]
14. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510 [TBL] [Abstract][Full Text] [Related]
15. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. Olive C; Hsien K; Horváth A; Clair T; Yarwood P; Toth I; Good MF Vaccine; 2005 Mar; 23(17-18):2298-303. PubMed ID: 15755615 [TBL] [Abstract][Full Text] [Related]
16. Molecular biology of Group A Brahmadathan NK Indian J Med Microbiol; 2017; 35(2):176-183. PubMed ID: 28681803 [TBL] [Abstract][Full Text] [Related]
17. Prospecting for new group A streptococcal vaccine candidates. McMillan DJ; Davies MR; Browning CL; Good MF; Sriprakash KS Indian J Med Res; 2004 May; 119 Suppl():121-5. PubMed ID: 15232176 [TBL] [Abstract][Full Text] [Related]
18. Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus. Tsoi SK; Smeesters PR; Frost HR; Licciardi P; Steer AC J Immunol Res; 2015; 2015():167089. PubMed ID: 26101780 [TBL] [Abstract][Full Text] [Related]
19. Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines? Smeesters PR; McMillan DJ; Sriprakash KS; Georgousakis MM Expert Rev Vaccines; 2009 Dec; 8(12):1705-20. PubMed ID: 19905872 [TBL] [Abstract][Full Text] [Related]
20. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans. Yang HL; Zhu YZ; Qin JH; He P; Jiang XC; Zhao GP; Guo XK BMC Genomics; 2006 Nov; 7():293. PubMed ID: 17109759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]